Hyppää sisältöön
    • Suomeksi
    • In English
Trepo
  • Suomeksi
  • In English
  • Kirjaudu
Näytä viite 
  •   Etusivu
  • Trepo
  • TUNICRIS-julkaisut
  • Näytä viite
  •   Etusivu
  • Trepo
  • TUNICRIS-julkaisut
  • Näytä viite
JavaScript is disabled for your browser. Some features of this site may not work without it.

Clinical, Serologic, and Histologic Characteristics in Screen-Detected and Clinically Diagnosed Celiac Disease Patients

Ahonen, Iida; Kivelä, Laura; Paavola, Aku; Laurikka, Pilvi; Huhtala, Heini; Sievänen, Harri; Kaukinen, Katri; Kurppa, Kalle (2026)

 
Avaa tiedosto
Clinical_Serologic_and_Histologic_Characteristics_in_Screen-Detected_and_Clinically_Diagnosed_Celiac_Disease_Patients.pdf (361.6Kt)
Lataukset: 



Ahonen, Iida
Kivelä, Laura
Paavola, Aku
Laurikka, Pilvi
Huhtala, Heini
Sievänen, Harri
Kaukinen, Katri
Kurppa, Kalle
2026

Gastro Hep Advances
100973
doi:10.1016/j.gastha.2026.100973
Näytä kaikki kuvailutiedot
Julkaisun pysyvä osoite on
https://urn.fi/URN:NBN:fi:tuni-202606026781

Kuvaus

Peer reviewed
Tiivistelmä
Background and Aims: The benefits of celiac disease screening remain debatable. We compared baseline characteristics and treatment outcomes between screen-detected and clinically diagnosed celiac disease adults in a prospective study. Methods: Clinical, serologic, and histologic data and bone mineral density (BMD) were assessed in 214 patients at diagnosis and after 1 year on gluten-free diet (GFD). Validated questionnaires were used to elicit gastrointestinal symptoms (Gastrointestinal Symptoms Rating Scale) and quality of life (Psychological General Well-Being questionnaire). Results: Screen-detected patients (n = 102) were older (median, 54 vs 43 years; P = .005), more often men (50% vs 16%; P < .001), and had higher mean lumbar T-score (−0.8 vs −1.2 standard deviation; P = .011) and hemoglobin levels (140 vs 128 g/dL; P < .001) at diagnosis than clinically diagnosed patients (n = 112). The groups were comparable in transglutaminase 2 (24.5 vs 47.7 U/mL; P = .051) and endomysial (1:200 vs 1:200; P = .385) autoantibody levels and histology assessed by villous height/crypt depth ratio (0.3 vs 0.3; P = .964). Screen-detected patients had fewer gastrointestinal symptoms (Gastrointestinal Symptoms Rating Scale total score 1.9 vs 2.6; P < .001) and better quality of life (Psychological General Well-Being questionnaire total score 107 vs 98; P = .001). After 1 year, both groups showed similar GFD adherence (94% vs 95%; P = .000) and improvements in histology, BMD, and quality of life. Asymptomatic and symptomatic screen-detected patients were comparable in histologic findings at diagnosis, adherence to GFD, and improvements in symptoms and quality of life. Conclusion: Screen-detected celiac disease patients demonstrated less severe symptoms and BMD impairment at diagnosis but advanced histologic and serologic disease similar to those identified on clinical grounds. Adherence to GFD and treatment response were comparable between the groups.
Kokoelmat
  • TUNICRIS-julkaisut [26189]
Kalevantie 5
PL 617
33014 Tampereen yliopisto
oa[@]tuni.fi | Tietosuoja | Saavutettavuusseloste
 

 

Selaa kokoelmaa

TekijätNimekkeetTiedekunta (2019 -)Tiedekunta (- 2018)Tutkinto-ohjelmat ja opintosuunnatAvainsanatJulkaisuajatKokoelmat

Omat tiedot

Kirjaudu sisäänRekisteröidy
Kalevantie 5
PL 617
33014 Tampereen yliopisto
oa[@]tuni.fi | Tietosuoja | Saavutettavuusseloste